Dr. Wassim Abida

Dr. Wassim Abida, MD, PhD, is a medical oncologist specializing in the care of patients with prostate cancer and other genitourinary cancers at Memorial Sloan Kettering Cancer Center. His clinical approach centers on individualized treatment planning, with a strong emphasis on balancing quality of life with the potential side effects of therapy. Working alongside colleagues in surgery, radiation oncology, and other specialties, he offers each patient a multidisciplinary care plan tailored to their specific situation and needs.

Dr. Abida's research is focused on understanding the underlying biology of prostate cancer in order to develop new and more effective therapies. A central component of his work involves molecular profiling, including genomic analysis, of prostate cancer to identify targetable pathways that can be explored through clinical trials. By characterizing the biological behavior of prostate cancer at a molecular level, he works to match emerging therapies to specific subsets of patients most likely to benefit from them.

In pursuit of these goals, Dr. Abida collaborates closely with laboratory-based colleagues across his institution, bridging the gap between bench research and clinical application. His commitment to translational science reflects a broader dedication to advancing care for patients with prostate cancer through precision medicine and novel drug development. His dual training in medicine and research positions him to contribute meaningfully to both the clinical management and the scientific understanding of genitourinary malignancies.